158 related articles for article (PubMed ID: 28238438)
1. ARID2 modulates DNA damage response in human hepatocellular carcinoma cells.
Oba A; Shimada S; Akiyama Y; Nishikawaji T; Mogushi K; Ito H; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Asahara H; Kaida A; Miura M; Tanabe M; Tanaka S
J Hepatol; 2017 May; 66(5):942-951. PubMed ID: 28238438
[TBL] [Abstract][Full Text] [Related]
2. BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
He DD; Shang XY; Wang N; Wang GX; He KY; Wang L; Han ZG
Oncogene; 2022 Mar; 41(10):1397-1409. PubMed ID: 35017665
[TBL] [Abstract][Full Text] [Related]
3. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
4. The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review.
Hu B; Lin JZ; Yang XB; Sang XT
Cell Prolif; 2020 Apr; 53(4):e12791. PubMed ID: 32162380
[TBL] [Abstract][Full Text] [Related]
5. Suppression of UV-induced apoptosis by the human DNA repair protein XPG.
Clément V; Dunand-Sauthier I; Clarkson SG
Cell Death Differ; 2006 Mar; 13(3):478-88. PubMed ID: 16167068
[TBL] [Abstract][Full Text] [Related]
6. ARID2: a new tumor suppressor gene in hepatocellular carcinoma.
Zhao H; Wang J; Han Y; Huang Z; Ying J; Bi X; Zhao J; Fang Y; Zhou H; Zhou J; Li Z; Zhang Y; Yang X; Yan T; Wang L; Torbenson MS; Cai J
Oncotarget; 2011 Nov; 2(11):886-91. PubMed ID: 22095441
[TBL] [Abstract][Full Text] [Related]
7. ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
Loesch R; Chenane L; Colnot S
Cells; 2020 Sep; 9(10):. PubMed ID: 32977645
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
Zhang L; Wang W; Li X; He S; Yao J; Wang X; Zhang D; Sun X
Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
[TBL] [Abstract][Full Text] [Related]
9. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
Li M; Zhao H; Zhang X; Wood LD; Anders RA; Choti MA; Pawlik TM; Daniel HD; Kannangai R; Offerhaus GJ; Velculescu VE; Wang L; Zhou S; Vogelstein B; Hruban RH; Papadopoulos N; Cai J; Torbenson MS; Kinzler KW
Nat Genet; 2011 Aug; 43(9):828-9. PubMed ID: 21822264
[TBL] [Abstract][Full Text] [Related]
10. XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells.
Wu Q; Beland FA; Chang CW; Fang JL
Toxicol Appl Pharmacol; 2011 Mar; 251(2):155-62. PubMed ID: 21192964
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
Fautrel A; Andrieux L; Musso O; Boudjema K; Guillouzo A; Langouët S
J Hepatol; 2005 Aug; 43(2):288-93. PubMed ID: 15922480
[TBL] [Abstract][Full Text] [Related]
13. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
[TBL] [Abstract][Full Text] [Related]
14. Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage.
Thorel F; Constantinou A; Dunand-Sauthier I; Nouspikel T; Lalle P; Raams A; Jaspers NG; Vermeulen W; Shivji MK; Wood RD; Clarkson SG
Mol Cell Biol; 2004 Dec; 24(24):10670-80. PubMed ID: 15572672
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitylation-independent degradation of Xeroderma pigmentosum group C protein is required for efficient nucleotide excision repair.
Wang QE; Praetorius-Ibba M; Zhu Q; El-Mahdy MA; Wani G; Zhao Q; Qin S; Patnaik S; Wani AA
Nucleic Acids Res; 2007; 35(16):5338-50. PubMed ID: 17693435
[TBL] [Abstract][Full Text] [Related]
16. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
[TBL] [Abstract][Full Text] [Related]
17. Correlations and co-localizations of Hsp70 with XPA, XPG in human bronchial epithelia cells exposed to benzo[a]pyrene.
Yang J; Liu X; Niu P; Zou Y; Duan Y
Toxicology; 2009 Nov; 265(1-2):10-4. PubMed ID: 19748547
[TBL] [Abstract][Full Text] [Related]
18. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes.
Athas WF; Hedayati MA; Matanoski GM; Farmer ER; Grossman L
Cancer Res; 1991 Nov; 51(21):5786-93. PubMed ID: 1933849
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
20. UV-induced apoptosis in XPG-deficient fibroblasts involves activation of CD95 and caspases but not p53.
Clément V; Dunand-Sauthier I; Wiznerowicz M; Clarkson SG
DNA Repair (Amst); 2007 May; 6(5):602-14. PubMed ID: 17208056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]